Literature DB >> 17891180

Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation.

L M Julian1, O Palander, L A Seifried, J E G Foster, F A Dick.   

Abstract

The retinoblastoma protein (pRB) has the dual capability to negatively regulate both E2F-induced cell cycle entry and E2F1-induced apoptosis. In this report, we characterize a unique pRB-E2F1 interaction. Using mutagenesis to disrupt E2F1 binding, we find that the ability of pRB to regulate E2F1-induced apoptosis is diminished when this interaction is lost. Strikingly, this mutant form of pRB retains the ability to control E2F responsive cell cycle genes and blocks cell proliferation. These functional properties are the reciprocal of a previously described E2F binding mutant of pRB that interacts with E2F1, but lacks the ability to interact with other E2Fs. Our work shows that these distinct interactions allow pRB to separately regulate E2F-induced cell proliferation and apoptosis. This suggests a novel form of regulation whereby separate types of binding contacts between the same types of molecules can confer distinct functional outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891180     DOI: 10.1038/sj.onc.1210803

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  DNA damage signals through differentially modified E2F1 molecules to induce apoptosis.

Authors:  Jasmyne Carnevale; Oliva Palander; Laurie A Seifried; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

2.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

3.  The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.

Authors:  Satyaki Sengupta; Raj Lingnurkar; Timothy S Carey; Monica Pomaville; Parimal Kar; Michael Feig; Catherine A Wilson; Jason G Knott; David N Arnosti; R William Henry
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

4.  RB goes mitochondrial.

Authors:  Laura D Attardi; Julien Sage
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

5.  An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences.

Authors:  Charles A Ishak; Aren E Marshall; Daniel T Passos; Carlee R White; Seung J Kim; Matthew J Cecchini; Sara Ferwati; William A MacDonald; Christopher J Howlett; Ian D Welch; Seth M Rubin; Mellissa R W Mann; Frederick A Dick
Journal:  Mol Cell       Date:  2016-11-23       Impact factor: 17.970

6.  Role of Drosophila retinoblastoma protein instability element in cell growth and proliferation.

Authors:  Jared S Elenbaas; Rima Mouawad; R William Henry; David N Arnosti; Sandhya Payankaulam
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.

Authors:  Hongjun Lv; Rui Liu; Jiao Fu; Qi Yang; Jing Shi; Pu Chen; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.

Authors:  J Bertin-Ciftci; B Barré; J Le Pen; L Maillet; C Couriaud; P Juin; F Braun
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

Review 9.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

Review 10.  Deciphering the retinoblastoma protein phosphorylation code.

Authors:  Seth M Rubin
Journal:  Trends Biochem Sci       Date:  2012-12-03       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.